DHTKD1 and neoplasm: One possibility towards this end is to replace the promoter that regulates transcription of the E1A gene in a E1B55-kDa-defective vector with a tumor-specific promoter, and this arrangement will ensure that replication of the viral vector will be activated only in tumor cells, while normal cells remain unaffected [89] [90].